Targeting for Prevention: The Logic of Funding an Ambitious Health Data Project https://t.co/hjftCVO3nG…
Symphony Health’s Jonathan Woodring, Julieanna Gubitosa, and Jennifer Rawding, all part of the company’s Commercial Effectiveness consulting practice, presented this week at the National Organization for Rare Disorders (NORD) annual Rare Summit, held in Arlington, VA. The team presented a poster titled “Leveraging Anonymous Patient Level Data to Identify Undiagnosed Rare Disease Patients” which discusses how deploying deductive and inductive algorithms can assist leaders in the rare disease space to increase important medical education, appropriate diagnosis, and life-changing treatment for those suffering from rare disease. The poster concludes that anonymized, patient-level data can and is helping increase the awareness, diagnosis, and treatment of patients in the rare disease space.
Access the full poster from the conference here.
We’ve made it easy to share this story with colleagues, friends or your favorite social media websites.